Evidence check: Hormoncheck Frauen in the context of fertility

A hormone check for women in the context of fertility typically includes measurements of AMH, FSH, LH, estradiol, progesterone, and sometimes TSH and prolactin. These biomarkers help assess ovarian reserve, ovulatory function, and endocrine disorders like PCOS or premature ovarian insufficiency. The evidence for these markers in clinical fertility evaluation is strong (human-strong), especially for AMH and FSH. However, the evidence for direct-to-consumer (DTC) hormone tests is more limited. Many home tests provide approximate values and may not match lab-grade accuracy due to variability in collection, handling, and assay methods. Additionally, single-point measurements can be misleading because hormone levels fluctuate with the menstrual cycle and time of day. Therefore, while a hormone check can offer useful insights, it should not replace a comprehensive fertility workup by a specialist. Genetic testing for hormone-related variants (e.g., FSH receptor) is still emerging and not yet standard practice. Safety note: Do not adjust medications or treatments based solely on a home test; always consult a healthcare provider.